The Valley Desk

NCT02467270 · Interventional trial

Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses

Overall registry status Completed

Phase 2

Conditions Myeloid Leukemia, Chronic, Chronic Phase

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov